| Biotechnology Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | 5 Sep 2023 Last Split | - IPO Date |
Green Lifescience Co., Ltd. positions itself as a highly dynamic entity within the biopharmaceutical realm, with its core objective centered around the innovation of healthcare solutions. The company is deeply ingrained in the field of research and development, focusing on the creation of novel diagnostic instruments, therapeutic biologics, and pharmaceutical products designed to meet critical healthcare needs. By pioneering new treatments and integrating technology into healthcare, Green Lifescience is making substantial contributions to the evolution of the healthcare industry. The company's activities are backed by in-depth scientific research and the diligent conduct of clinical trials. Operating globally, Green Lifescience supplies health professionals and institutions with superior products that significantly enhance patient care. In the financial sphere, the company is recognized for its substantial contributions to the advancement of life sciences, a factor that is crucial for the growth of related sectors such as biotechnology and pharmaceuticals.
Green Lifescience Co., Ltd. offers a diverse array of products and services, which include: